A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors Meeting Abstract
| Authors: | Hyman, D. M.; Brana, I.; Spreafico, A.; Schram, A. M.; Pandya, N. B.; Hoffman, K.; Hallet, R.; Giblin, P.; Anido, J.; Ruano, I. H.; Wasserman, R.; Magram, J.; Siu, L. L.; Tabernero, J.; Seoane, J.; Baselga, J. |
| Abstract Title: | A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 131s |
| Language: | English |
| ACCESSION: | WOS:000442916007548 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS2602 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2602 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work